Search company, investor...

Endocardial Solutions

Founded Year



Acquired | Acquired

Total Raised






About Endocardial Solutions

Mapping and other diagnostics for irregular heart rhythms. IPO 1997. Acquired by St. Jude Medical in 2005.

Headquarters Location

1350 Energy Lane Suite 110

Saint Paul, Minnesota, 55108,

United States


Missing: Endocardial Solutions's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Endocardial Solutions's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Endocardial Solutions Frequently Asked Questions (FAQ)

  • When was Endocardial Solutions founded?

    Endocardial Solutions was founded in 1992.

  • Where is Endocardial Solutions's headquarters?

    Endocardial Solutions's headquarters is located at 1350 Energy Lane, Saint Paul.

  • What is Endocardial Solutions's latest funding round?

    Endocardial Solutions's latest funding round is Acquired.

  • How much did Endocardial Solutions raise?

    Endocardial Solutions raised a total of $24.77M.

  • Who are the investors of Endocardial Solutions?

    Investors of Endocardial Solutions include St. Jude Medical, Wasatch Advisors, SF Capital Group, Epic Ventures, Heartland Group and 7 more.

  • Who are Endocardial Solutions's competitors?

    Competitors of Endocardial Solutions include Ativa Medical, Cardiac Science Corporation, Third Eye Diagnostics, CardioInsight Technologies, Signature Diagnostics and 11 more.

Compare Endocardial Solutions to Competitors

Ativa Medical

Ativa Medical is a medical diagnostics company that is working to make diagnostic test results available in moments, rather than hours and days.


LabNow has developed the LabNow System to conduct healthcare-related diagnostics at the point-of-care.


ProteoGenix offers maternal-fetal diagnostics


AngioLogix is a provider of cardiovascular health diagnostics.

Sober Steering Logo
Sober Steering

Sober Steering develops transdermal technologies as means for detecting driver intoxication.


Cervimark is a medical diagnostics company that is developing a screening test for the prediction of pregnancies at high risk for preterm delivery. The test is based on quantifying biomarkers found in secretions of pregnant patients and correlating the resulting data to risk of pre-term labor. Proof of concept for this test has been demonstrated in a small human trial.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.